loader image
Sunday, November 30, 2025
71.9 F
McAllen
- Advertisement -

Dr. Surendra Varma Appointed to Texas Medical Board District Three Review Committee

Translate to Spanish or other 102 languages!

Governor Greg Abbott has appointed Surendra Varma, M.D. to the Texas Medical Board (TMB) District Three Review Committee for a term set to expire on January 15, 2026. Image source: Facebook
Governor Greg Abbott has appointed Surendra Varma, M.D. to the Texas Medical Board (TMB) District Three Review Committee for a term set to expire on January 15, 2026. Image source: Facebook
- Advertisement -

AUSTIN – Governor Greg Abbott has appointed Surendra Varma, M.D. to the Texas Medical Board (TMB) District Three Review Committee for a term set to expire on January 15, 2026.

Surendra Varma, M.D. of Lubbock is the executive associate dean for graduate medical education at the Texas Tech University Health Sciences Center (TTUHSC) and is a Grover E. Murray Professor and Ted Hartman Endowed Chair in Medical Education at TTUHSC. He is an associate editor for Advances in Pediatrics, editorial board member for the Journal of Clinical Endocrinology and Metabolism, and a member of the American Pediatric Society, Society for Pediatric Research, Endocrine Society, and the Council on Graduate Medical Education for the Health Resources & Services Administration. He is a member and former president of the American Diabetes Association and a member and former Texas affiliate chair of endocrinology for the American Academy of Pediatrics. Previously, he served as a gubernatorial appointee on the TMB District Three Review Committee for six years, TMB for five years, and the Task Force on Infectious Disease Preparedness and Response for four years. Varma received a Bachelor of Science in Physics, Chemistry, Biology and English from the University of Lucknow, and a Bachelor of Medicine, a Bachelor of Surgery, and a Doctor of Medicine in Pediatrics from King George Medical University (KGMU). He has received honorary Doctorate (DSc) from KGMU and Honorary Fellowship (FRCP) from Royal College of Physicians. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.

Educating Older Adults On Age-Related Weight Gain, Dec. 5th

The “Living with Weight Gain” program is part of STHS & Prominence Health’s “Senior Living Seminar Series,” which focuses on providing essential education on common health issues affecting the elderly population
- Advertisement -
×